Abbott Laboratories (N:ABT)

Business Focus: Medical Equipment

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
 
See Regulatory Filings on SEC
Company Contact
Address: 100 Abbott Park Rd
ABBOTT PARK IL 60064-3500
Tel: N/A
Website: www.abbott.com
IR: See website
<
Key People
Miles D. White
Chairman of the Board, Chief Executive Officer
Robert B. Ford
President, Chief Operating Officer
Brian B. Yoor
Chief Financial Officer, Executive Vice President - Finance
Hubert L. Allen
Executive Vice President, General Counsel, Secretary
Jaime Contreras
Senior Vice President - Core Laboratory Diagnostics, Commercial Operations
Daniel Gesua Sive Salvadori
Senior Vice President - Established Pharmaceuticals, Latin America.
Business Overview
Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the United States. Its Diagnostic Products include a range of diagnostic systems and tests. Its Nutritional Products include a range of pediatric and adult nutritional products. Its Company's Vascular Products include a range of coronary, endovascular, vessel closure and structural heart devices for the treatment of vascular disease. The Company, through St. Jude Medical, Inc., also offers products, such as rhythm management products, electrophysiology products, heart failure related products, vascular products, structural heart products and neuromodulation products.
Financial Overview
For the six months ended 30 June 2019, Abbott Laboratories revenues increased 2% to $15.51B. Net income before extraordinary items increased 40% to $1.6B. Revenues reflect Other segment increase of 31% to $1.2B, Vascular Products segment increase of 1% to $4.8B, Nutritionals segment increase of 1% to $3.67B, United States segment increase of 4% to $5.6B, All other Countries segment increase of 1% to $9.91B.
Employees: 103,000 as of Dec 31, 2018
Reporting Currency: U.S. Dollars
Enterprise value: $165,234M as of Jun 30, 2019
Annual revenue (TTM): $30,935M as of Jun 30, 2019
EBITDA (TTM): $7,256M as of Jun 30, 2019
Net annual income (TTM): $2,921M as of Jun 30, 2019
Free cash flow (TTM): $1,974M as of Jun 30, 2019
Net Debt Last Fiscal Year: $15,818M as of Jun 30, 2019
Shares outstanding: 1,767,397,615 as of Jun 30, 2019
Index Membership: S&P 500
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization